GENEVA, June 19 -- REGENERON PHARMACEUTICALS, INC. filed a patent application (US2025/055000) for “SYSTEMS AND METHODS FOR DRUG DELIVERY TO OCULAR TISSUE”. With publication no. WO/2026/106974, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61F 9/00
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....